| 0 (0%) | 11-11 17:42 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 73.03 | 1-year : | 85.3 |
| Resists | First : | 62.52 | Second : | 73.03 |
| Pivot price | 61.58 |
|||
| Supports | First : | 61.41 | Second : | 60.72 |
| MAs | MA(5) : | 61.69 |
MA(20) : | 61.67 |
| MA(100) : | 60.38 |
MA(250) : | 57.09 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 79.1 |
D(3) : | 57.7 |
| RSI | RSI(14): 61.2 |
|||
| 52-week | High : | 62.52 | Low : | 49.74 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ IGF ] has closed below upper band by 2.2%. Bollinger Bands are 7.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 62.49 - 62.74 | 62.74 - 62.98 |
| Low: | 61.51 - 61.81 | 61.81 - 62.1 |
| Close: | 61.89 - 62.34 | 62.34 - 62.78 |
Thu, 06 Nov 2025
Devils Announce Ambassadors to NHL, NHLPA's IGF Programs for 2025-26 | RELEASE - NHL.com
Thu, 06 Nov 2025
IGF-1 Regulates Cancer Cell Immune Evasion in Prostate Cancer - Oncodaily
Mon, 03 Nov 2025
IGF-1 regulates cancer cell immune evasion in prostate cancer - Nature
Sat, 01 Nov 2025
A Rare Case of Presumed Insulin-Like Growth Factor 2 (IGF-2)-Mediated Hypoglycemia - The Cureus Journal of Medical Science
Fri, 22 Aug 2025
Regulation of feather length: FGF/IGF signaling and NOTCH/YAP modulation of progenitor cell topology - Science | AAAS
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|